← Open Payments lookup

FRANK GOLDEN: Open Payments

NPI 1033704051 · LEHIGHTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,847 in 104 payments from 14 companies in 2025. Trend: 2023 $2,090 · 2024 $1,392 · 2025 $1,847

Food & beverage: $1,847
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.17$353
ABBVIE INC.21$314
Otsuka America Pharmaceutical, Inc.13$299
Alkermes, Inc.11$215
Vanda Pharmaceuticals Inc.10$169
E.R. Squibb & Sons, L.L.C.13$162
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$74
Janssen Pharmaceuticals, Inc3$59
Lundbeck LLC3$45
Braeburn Inc.2$42

Products named: INGREZZA, VRAYLAR, REXULTI, ARISTADA, COBENFY, FANAPT, CAPLYTA, INVEGA SUSTENNA.

Industry payments across PA — which companies pay providers there.